Company · London
Mosaic Therapeutics Limited
Research and experimental development on biotechnology
Official record Companies House · updated 27th September 2026 · Sources
Network
The large node is Mosaic Therapeutics Limited. Red nodes are organisations, white nodes are people. Sign in free to explore further.
Who leads it
Previous officers 12
- Dr John Tsai 2023-2024 View profile
- Brian Scott Gladsden 2023-2024 View profile
- Dr Adrian Paul Ibrahim 2022-2023 View profile
- Magdalena Anna Jonikas 2022-2026 View profile
- Dr Viet-Anh Anne Horgan 2022-2024 View profile
- Dr Christopher John Hollowood 2022-2023 View profile
- Dr Sally Louise Bennett 2022-2024 View profile
- Dr Cordelia Florence Langford 2021-2022 View profile
- Suzannah Gozna 2021-2021 View profile
- Margaret Susan Payne 2020-2022 View profile
- Carys Stedman-Lloyd 2022-2022 View profile
- Lise Erica Richards 2020-2022 View profile
Directors and secretaries as filed at Companies House.
Do you help lead this organisation? Set up its network · How it works
About
- What it does
- Research and experimental development on biotechnology
- Incorporated
- 30/07/2020
- Registered office
- London
Ownership
Owned by (1) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.
- Genome Research Limited ceased 2022-10-17
75-100% shares, 75-100% voting, appoints directors · notified 2020-07-30
Group
- Mosaic Therapeutics Limited
is controlled by Genome Research Limited
Evidence
ceased 75-100% shares, 75-100% voting, appoints directors · notified 2020-07-30, ceased 2022-10-17 · source: Companies House PSC register
Ultimately controlled by Genome Research Limited.
6 other companies in this group
Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.
Board analysis
Board DNA
How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.
5 directors on the board
- Dr Laurence Edward Reid Director · appointed 2024
- Richard Francis Wooster Director · appointed 2026
- Edward Eliot Hodgkin Director · appointed 2023
- Dr Mathew James Garnett Director · appointed 2022
- Thomas Fuchs Director · appointed 2025
First-time vs portfolio directors
First-time (2)
- Dr Mathew James Garnett Director · appointed 2022
- Thomas Fuchs Director · appointed 2025
Portfolio (3)
- Dr Laurence Edward Reid Director · appointed 2024
- Richard Francis Wooster Director · appointed 2026
- Edward Eliot Hodgkin Director · appointed 2023
Left in the last 12 months
- Magdalena Anna Jonikas Director · appointed 2022 · resigned 2026
Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.
The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.
Gaps to watch
- Narrow spread of sectors across the board
Where to look Suggested search: directors from a wider range of sectors.
Sources
Official record from Companies House. Governance Register calculates the connections.
Record details
- Company number
- 12780154
- Status
- Active
- Type
- Private Limited Company
- Accounts next due
- 30/09/2027
- Edition
- Register edition compiled 27th September 2026
- Labels
- Official record from Companies House · Calculated derived by Governance Register.
Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data